Devices & Diagnostics Letter

Aug. 27, 2012 | Vol. 39 No. 34

CMS Updates TAVR Coverage, Adding CoreValve Trial Use

Medicare will cover patients enrolled in Medtronic’s pivotal trial of the CoreValve system, under an Aug. 10 revision to the Centers for Medicare & Medicaid Services’ (CMS) coverage policy on transcatheter aortic valve replacement (TAVR).

This article is viewable by subscribers only. To view this article, please select an option below.

Subscribe
Print This Page
RSS
Free Trial
Archives
Sample PDF

Medtronic Renal Denervation Device Earns Parallel FDA, CMS Review Official: Consider How Sunshine Reports May Look to Enforcement Before Filing White House Ignores Grassley’s Deadline on Sunshine Act CMS Sunshine Act Rule Reaches OMB, on Track for Publication Within 90 Days

Home
Advertising/Sponsorships
About Us
Contact Us
Site Map
Privacy Policy

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA.
Phone (703) 538-7600 - Fax (703) 538-7676 - Toll free (888) 838-5578.